Werk 11 — who carries it
The ventures are not a side portfolio. They are where the collective's delivery doctrine is exercised without a client absorbing the risk, and where a method either survives contact with production or gets discarded.
The offer
A venture taken from specification to a running platform by the people who will be held to it — the same standard as client delivery, with the economics structured up front.
Domain corpus research, functional and non-functional specification at scale, and the architecture the venture will be built on.
Product, platform and design system built from nothing to a regulated, operable service with a real first user.
Positioning, pricing, the metrics investors will ask for, and the documentation a due diligence will request.
Equity, cost-sharing and the operating agreement between founders and the collective.
Domain corpus, specification, architecture and build estimate.
The platform built and operated, in cash or in equity.
The venture run from inside until it can run itself.
State of the proof
Experiences that prove it
Sub-capabilities and evidence
Publishable figures
Questions
- What do the ventures prove?
- That the collective can carry a regulated platform from an empty repository to a specified, gated, multi-market system. On-Kare carries 2,155 feature specifications across 12 compliance frameworks and 9 APAC markets. Phoeniks carries 319, of which 59% are rated high or critical on regulatory criticality.
- Why does a client care about the ventures?
- Because they are the only place the collective's methods are exercised at full scale with nobody else absorbing the risk. The specification discipline, the seven-level clinical severity scale, the risk tiering and the AI gateway shipped inside On-Kare are the same ones a client mandate inherits — already tested against a regulated corpus rather than proposed on a slide.
- What does venture-grade specification look like?
- On-Kare carries 2,155 feature specifications on a fixed 108-key schema across 12 compliance frameworks, 9 APAC markets and 10 clinical specialties. Phoeniks carries 319 with continuous numbering and no gaps, of which 59% are rated high or critical on regulatory criticality. Both are machine-checkable, which is what makes them specifications rather than intentions.